<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03924375</url>
  </required_header>
  <id_info>
    <org_study_id>SCH-HP-2019</org_study_id>
    <nct_id>NCT03924375</nct_id>
  </id_info>
  <brief_title>Serum Pepsinogen After H. Pylori Eradication</brief_title>
  <official_title>Serum Pepsinogen After Helicobacter Pylori Eradication for the Gastric Cancer Prevention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Soonchunhyang University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Soonchunhyang University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Helicobacter pylori has been recognized as a major pathogen in gastric carcinogenesis.&#xD;
      Current guidelines recommend the H. pylori &quot;test-and-treat&quot; strategy for the purpose of&#xD;
      primary and secondary gastric cancer prevention. Considering the &quot;point of no return&quot; theory,&#xD;
      however, H. pylori eradication cannot reduce the risk of gastric cancer in subjects with&#xD;
      gastric atrophy and intestinal metaplasia. The intragastric hypoacidic environment is&#xD;
      associated with the risk of intestinal-type gastric cancer development. Recently, the&#xD;
      secretory ability of the stomach can be measured using the serum pepsinogen (PG) assay.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aimed to evaluate the change of serum PGs after H. pylori eradication success and&#xD;
      identify the optimal timing of eradication.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 15, 2019</start_date>
  <completion_date type="Actual">May 31, 2020</completion_date>
  <primary_completion_date type="Actual">March 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Serum pepsinogen change after H. pylori eradication</measure>
    <time_frame>after 8 weeks</time_frame>
    <description>Serum pepsinogen recovery</description>
  </primary_outcome>
  <enrollment type="Actual">100</enrollment>
  <condition>Helicobacter Pylori Eradication</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Biospecimen would be obtained for urease test (commercial name: CLOtest).&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        H. pylori-infected subjects who underwent an upper gastrointestinal endoscopy were enrolled&#xD;
        in this study at a single, tertiary-care, academic medical center.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Gastroscopy can be performed&#xD;
&#xD;
          -  Serologic markers including serum pepsinogen can be measured&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 20 or &gt; 70 years&#xD;
&#xD;
          -  Anemia (serum hemoglobin level &lt; 10 g/dL)&#xD;
&#xD;
          -  Severe systemic disease&#xD;
&#xD;
          -  Advanced chronic liver disease&#xD;
&#xD;
          -  Use of certain medications, including proton pump inhibitors, H2- receptor&#xD;
             antagonists, or antibiotics&#xD;
&#xD;
          -  History of H. pylori eradication&#xD;
&#xD;
          -  History of gastric surgery&#xD;
&#xD;
          -  Recent history of upper gastrointestinal bleeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jun-Hyung Jun-Hyung, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Digestive Disease Center, Soonchunhyang University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Digestive Disease Center, Soonchunhyang University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>04401</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>April 20, 2019</study_first_submitted>
  <study_first_submitted_qc>April 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2019</study_first_posted>
  <last_update_submitted>July 24, 2020</last_update_submitted>
  <last_update_submitted_qc>July 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Soonchunhyang University Hospital</investigator_affiliation>
    <investigator_full_name>Jun-Hyung Cho</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

